Nuvectis Pharma, Inc. (NVCT) News
Track canonical SquawkNews coverage tagged to NVCT, Nuvectis Pharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 18 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Nuvectis Pharma Price Target Maintained With a $39.00/Share by HC Wainwright & Co.
Ratings actions from Benzinga
NEWS | Sep 24, 2026, 02:42 PM UTC
L
Nuvectis Pharma, Inc. (NVCT) Wins China Breakthrough Therapy for NXP200
Nuvectis said China’s CDE granted Breakthrough Therapy Designation to NXP200 for BRAF V600—mutant, recurrent or progressive high—grade glioma. Nuvectis holds ex—Greater China rights and plans a U.S. IND submission in Q4
GEOPOLITICS | Sep 24, 2026, 12:03 PM UTC
L
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
Fort Lee, NJ, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. NASDAQ:NVCT ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the trea
GEOPOLITICS | Sep 24, 2026, 12:03 PM UTC
L
Nuvectis Pharma to participate in upcoming investor conferences
Nuvectis Pharma said it will participate in upcoming investor conferences. The clinical-stage biopharmaceutical company focuses on complement-related conditions and oncology.
EQUITY | Sep 03, 2026, 12:07 PM UTC
L
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
WSW, NY, September 3rd, 2026, FinanceWireThe latest filings showing the institutional holdings for Nuvectis Pharma NASDAQ:NVCT appeared a few weeks ago, and for the first time they gave a clear look at who actually put u
EQUITY | Sep 03, 2026, 12:06 PM UTC
L
NVCT - Nuvectis Pharma To Participate in Upcoming Investor Conferences
NVCT - Nuvectis Pharma To Participate in Upcoming Investor Conferences
EQUITY | Sep 03, 2026, 12:00 PM UTC
L
NVCT initiated with Overweight rating by Cantor Fitzgerald
Hammerstone MarketTalk says NVCT is initiated with an Overweight rating at Cantor Fitzgerald, with no additional figures, target, or rationale provided.
EQUITY | Aug 24, 2026, 11:59 AM UTC
L
Cantor initiates NVCT at Overweight
Cantor initiates coverage of NVCT with an Overweight rating, with no catalyst, price target, or additional details supplied in the alert.
EQUITY | Aug 24, 2026, 11:13 AM UTC
L
NVCT - Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
NVCT - Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
EARNINGS | Aug 04, 2026, 12:03 PM UTC
L
IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo cut the price targ
EQUITY | Jul 06, 2026, 12:21 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ: CELZ ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million. Cuprina Holdings (Cayman) (NASDAQ: C
EQUITY | Jun 30, 2026, 05:05 PM UTC
H
Select Premarket Movers
Upside: -AVAV +35% (earnings, guidance) -VWAV +29% (acquires 51% controlling interest in private Israeli aerospace and defense company Meteor Aerospace for ~$20.4M in stock) -SEDG +11% (solar stock strength following FCC
GEOPOLITICS | Jun 30, 2026, 12:26 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC
H
Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
Shares of AeroVironment, Inc. (NASDAQ: AVAV ) rose sharply in pre-market trading after the company reported better-than-expected financial results for the fourth quarter of fiscal 2026. AeroVironment guided for fiscal 20
EARNINGS | Jun 30, 2026, 10:10 AM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Wednesday's intraday session, with Pulsenmore and Icecure Medical leading the gainers and Aditxt and Atlantic International among the losers
EQUITY | Jun 24, 2026, 05:05 PM UTC
H
NVCT Surges 20%
Nuvectis Pharma's stock surges 20% after announcing a strategic portfolio expansion through a license agreement with Haisco Pharmaceutical Group
EQUITY | Jun 23, 2026, 06:34 AM UTC
M
NVCT Licenses Compounds
Nuvectis Pharma strikes license agreement with Haisco Pharmaceutical Group for exclusive ex-China rights to two compounds
EQUITY | Jun 22, 2026, 11:41 AM UTC
M
NVCT Expands Portfolio
Nuvectis announces strategic portfolio expansion via license agreement with Haisco Pharmaceutical Group for two clinical-stage compounds
EQUITY | Jun 22, 2026, 11:31 AM UTC